期刊文献+

替米考星对内毒素炎症小鼠存活率和细胞因子的影响 被引量:2

Effects of tilmicosin on cytokine response and survival rate of inflammatory mice by LPS
原文传递
导出
摘要 替米考星按20 mg/kg剂量经灌胃给药后,观察其对内毒素(LPS)炎症小鼠的保护率,并通过不同时间段眼球采血,分离血清,应用试剂盒用酶联免疫吸附分析(Enzyme-linked i mmunosorbent assy,ELISA)法测定小鼠血清中肿瘤坏死因子-α(TNF-α)、白细胞介素-10(IL-10)、白细胞介素-6(IL-6)、白细胞介素-1(IL-1β)的水平。结果表明,替米考星明显提高了内毒素炎症小鼠的存活率,死亡率由100%降低为50%(P<0.05)。LPS(20 mg/kg)能提高血清中TNF-α、IL-10、IL-6和IL-1β的水平,替米考星能够显著抑制TNF-α、IL-6和IL-1β的释放,而明显提高IL-10的水平。 The inflammation mice model was established by intraperitoneal injection of LPS(20 mg/kg),and administered the tilmicosin (20 mg/kg) by gavage. The results showed the tilmieosin remarkably improved the survival rate of mice challenged with LPS. Compared with LPS group at 24 hour,the mortality of timilcosin group obviously dropped from 100% to 50% (P〈0.05). There was a distinct decrease in serou TNF -α,IL-10,IL -6 and IL-1β contents and increase in serou IL- 10 levels in tilmicosin group compared with LPS group.
出处 《中国兽医学报》 CAS CSCD 北大核心 2009年第9期1186-1188,共3页 Chinese Journal of Veterinary Science
基金 国家自然科学基金资助项目(30270999)
关键词 替米考星 内毒素 炎症小鼠 细胞因子 tilmicosin endotoxemia inflammatory mice cytokine
  • 相关文献

参考文献12

  • 1Fujihara M, Muroi M, Tanamoto K, et al. Molecular mechanisms of macrophage activation and deactivation by lipopolysaccharide: roles of the receptor complex [J]. Pharmacol Ther, 2003,100 : 171-194.
  • 2Remick D G, Stricter R M, Eskandari M K, et al. Role of tumor necrosis factor alpha in lipopolysaccharide-induced pathologic alterations [J]. Am J Pathol, 1990, 136:49-60.
  • 3Mozes T,Ben-Efraim S,Tak C J,et al. Serum levels of tumor necrosis factor determine the fatal or non fatal course of endotoxic shock[J]. Immunol Lett, 1991,27: 157-162.
  • 4Martich G D,Boujoukos A J, Suffredini A F. Response of man to endotoxin[J]. Immunobiology, 1993, 187: 403-416.
  • 5Berg D J,Kuhn R,Rajewsky K,et al. Interleukin-10 is a central regulator of the response to LPS in murine models of endotoxic shock and the Shwartzman reaction but not endotoxin tolerance [J]. J Clin Invest, 1995,96:2339-2347.
  • 6Karima R, Matsumoto S, Higashi H, et al. The molecular pathogenesis of endotoxic shock and organ failure [J]. Mol Med Today,1999(5):123-132.
  • 7Gerard C,Bruyns C,Marchant A,et al. Interleukin 10 reduces the release of tumor necrosis factor and prevents Lethality in experimental endotoxemia[J]. J Exp Med, 1993,177 : 547-550.
  • 8Fodor L,Reeve Johnson L, Hodge A,et al. Efficacy evaluations of the use of oral tilmicosin in pneumonic calves[J]. Vet J ,2000,159 : 194-200.
  • 9Naccari F, Giofre F, Pellegrino M, et al. Effectiveness and kinetic behaviour of tilmicosin in the treatment of respiratory infections in sheep[J]. Vet Rec,2001,148 : 773-776.
  • 10Moore G M, Mowrey D H, Tonkinson I. V, et al. Efficaey dose determination study of titmicosin phosphate in feed for control of pneumonia caused by Actinobacillus pleuropneumo.iae in swine[J]. Am J Vet Res, 1996.57: 220-223.

二级参考文献1

  • 1J. Bauer,F. Herrmann. Interleukin-6 in clinical medicine[J] 1991,Annals of Hematology(6):203~210

共引文献11

同被引文献20

  • 1宋福杰,刘明春,符特.替米考星的应用研究进展[J].现代畜牧兽医,2006(7):63-65. 被引量:7
  • 2Florian Priese, Bertram Wolf. Development of high drug loaded pellets by Design of Experiment and population balance model calculation[ J]. Powder Technology,2013, 241 : 149 - 157.
  • 3X F Wang, S L Zhang, L Y.Enhancement of antibacterial of tivity of tilmicosin against Staphylococcus aureus by solid lipid nanoparticles in vitro and in vivo [ J ]. The Veterinary Journal, 2012, 1 (191): 115-120.
  • 4Fridrun Podczeck, John Michael Newton. Influence of the standing time of the extrudate and speed of rotation of the spheroniser plate on the properties of pellets produced by extrusion and spheronization [ J]. Advanced Powder Technolog. In Press, http://dx.doi.org/ 10.1016/j.apt. 2013.10.011.
  • 5P E Knight, F Podczeck, J M Newton. The theological properties of modified microcrystalline cellulose containing high levels of model drugs[J]. J Pharm Sci,2009, 98 : 2160 - 2169.
  • 6中国药典国家药典委员会.中华人民共和国药典2010年版第二部附录[S].
  • 7Pan Chen. Novel compaction techniques with pellet containing granules[J]. Eur J Pharm Biopharm,2010, 3(75) : 436-442.
  • 8李连闯,车文实.微丸成型工艺研究进展[J].安徽医科大学报,2013,48(4):453-455.
  • 9Akhgari A, Abbaspour M R, Moradkhanizadeh M. Combination of Pectin and Eudargit RS and Eudragit RL in the Matrix of PelletsPrepared by Extrusion-Spheronization for Possible Colonic Delivery of 5 - Amino Salicylic Acid [ J ]. Jundishapur journal of Natural Pharmaceutical Products,2013, 8(2) : 86-92.
  • 10萧惠来.VICH兽药靶动物安全性研究指导原则概述[J].中国兽药杂志,2009,43(12):33-37. 被引量:35

引证文献2

二级引证文献12

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部